SCHEMBL13614264

SCHEMBL13614264

COC(=O)Cc1ccc(-c2cc(O)c3c(c2)C(C)(C)CCC3=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
RXRA P19793 2/20 0.37
RXRB P28702 2/20 0.37
RXRG P48443 2/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
HSP90AB1 P08238 1/20 0.36
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
CHEK1 O14757 2/20 0.34
PPARG P37231 1/20 0.34
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
EPHX2 P34913 1/20 0.33
PDK2 Q15119 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13614262 0.85 RXRA (0.35) ALDH1A1GAAGFERRXRARXRB
SCHEMBL14525074 0.84 RXRA (0.37) ALDH1A1RXRARXRBRXRGCYP4F2
SCHEMBL4518421 0.84 ALDH1A1 (0.38) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL13614267 0.80 PDK2 (0.34) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL13613955 0.78 RARG (0.38) ALDH1A1RXRARXRBRXRGRARA
SCHEMBL13613912 0.72 RXRA (0.46) GAARXRARXRBRXRGLMNA
SCHEMBL13613956 0.72 ALDH1A1 (0.37) ALDH1A1GAAGFERRXRARXRB
SCHEMBL4511400 0.72 RARB (0.35) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL4511518 0.72 ACACB (0.35) RARARARBRARGCYP26A1CYP26B1
SCHEMBL4511522 0.71 ACACB (0.37) RXRARARARARBRARGPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638648-B2 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN INC. (US) 2009-12-29 US disclosed
US-20080004455-A1 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN, INC. (US) 2008-01-03 US disclosed
US-7226951-B2 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN, INC. (US) 2007-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004455-A1 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same CYP1A2, CYP2A7, CYP3A7 ALDH1A1 96/4885GAA 904/4885GFER 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.